Aducanumab: A Deep Dive into BIIB037 and its Impact The medication, initially known as BIIB037, represents a significant effort to treat emerging Alzheimer's illness. Developed by Biogen, this molecule acts by removing https://lawsonnpek431452.blog5.net/92382774/text